Editas Medicine, Inc. Quarterly Current Ratio in % from Q3 2016 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Editas Medicine, Inc. quarterly Current Ratio history and growth rate from Q3 2016 to Q2 2024.
  • Editas Medicine, Inc. Current Ratio for the quarter ending June 30, 2024 was 492 %, a 32% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 492 -232 -32% Jun 30, 2024
Q1 2024 595 -205 -25.6% Mar 31, 2024
Q4 2023 627 -366 -36.8% Dec 31, 2023
Q3 2023 643 -525 -44.9% Sep 30, 2023
Q2 2023 724 -468 -39.3% Jun 30, 2023
Q1 2023 801 -292 -26.7% Mar 31, 2023
Q4 2022 993 -26.4 -2.59% Dec 31, 2022
Q3 2022 1.17K +233 +24.9% Sep 30, 2022
Q2 2022 1.19K +296 +33.1% Jun 30, 2022
Q1 2022 1.09K +208 +23.5% Mar 31, 2022
Q4 2021 1.02K +236 +30% Dec 31, 2021
Q3 2021 935 +138 +17.3% Sep 30, 2021
Q2 2021 895 +198 +28.4% Jun 30, 2021
Q1 2021 884 +306 +53% Mar 31, 2021
Q4 2020 784 +172 +28% Dec 31, 2020
Q3 2020 797 +157 +24.5% Sep 30, 2020
Q2 2020 697 -92.6 -11.7% Jun 30, 2020
Q1 2020 578 -534 -48% Mar 31, 2020
Q4 2019 613 -608 -49.8% Dec 31, 2019
Q3 2019 640 -537 -45.6% Sep 30, 2019
Q2 2019 790 -317 -28.7% Jun 30, 2019
Q1 2019 1.11K +206 +22.8% Mar 31, 2019
Q4 2018 1.22K +426 +53.7% Dec 31, 2018
Q3 2018 1.18K +454 +62.8% Sep 30, 2018
Q2 2018 1.11K +371 +50.5% Jun 30, 2018
Q1 2018 906 +34.6 +3.97% Mar 31, 2018
Q4 2017 794 -398 -33.4% Dec 31, 2017
Q3 2017 723 -1.07K -59.8% Sep 30, 2017
Q2 2017 735 Jun 30, 2017
Q1 2017 871 Mar 31, 2017
Q4 2016 1.19K Dec 31, 2016
Q3 2016 1.8K Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.